The objective of this clinical trial was to explore the efficacy of reparixin in preventing graft dysfunction after islet transplantation in type 1 diabetes patients (T1D).
Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus
Sites will comply with any additional exclusion criteria locally accepted, as per centre practice.
Copyright 2017 © Dompé farmaceutici S.p.A. All rights reserved.
Dompè does not assume any responsibility for the contents